Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis
Jarrod W. Barnes, Dawn Duncan, Scott Helton, et al.
AJP Lung Cellular and Molecular Physiology (2019) Vol. 317, Iss. 1, pp. L141-L154
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 136
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 98
Klotho attenuates epithelial‑mesenchymal transition of retinal pigment epithelial cells in subretinal fibrosis by suppressing the ERK1/2 and Wnt/β‑catenin signaling pathways
Y.-L. Jiang, Xuewei Wen, Xiaoyu Jian, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access | Times Cited: 2
Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease
Molly Easter, Seth Bollenbecker, Jarrod W. Barnes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6924-6924
Open Access | Times Cited: 81
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
Juan R. Muñoz‐Castañeda, Cristian Rodelo‐Haad, M. Victoria Pendón-Ruiz de Mier, et al.
Toxins (2020) Vol. 12, Iss. 3, pp. 185-185
Open Access | Times Cited: 73
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
Yi Zhu, Larissa Prata, Erin O. Wissler Gerdes, et al.
EBioMedicine (2022) Vol. 77, pp. 103912-103912
Open Access | Times Cited: 58
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Hongbo Ma, Shengming Liu, Shanrui Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Lung-kidney interactions and their role in chronic kidney disease-associated pulmonary diseases
Seth Bollenbecker, Brian Czaya, Orlando M. Gutiérrez, et al.
AJP Lung Cellular and Molecular Physiology (2022) Vol. 322, Iss. 5, pp. L625-L640
Closed Access | Times Cited: 25
Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities
Fernanda Hernández‐González, Federico Pietrocola, Paolo Cameli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7554-7554
Open Access | Times Cited: 5
Landscape genomics reveals adaptive divergence of indigenous sheep in different ecological environments of Xinjiang, China
Cheng-long Zhang, Jihu Zhang, Mirenisa Tuersuntuoheti, et al.
The Science of The Total Environment (2023) Vol. 904, pp. 166698-166698
Open Access | Times Cited: 13
The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
Mada Ghanem, Gabrielle Archer, Bruno Crestani, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108669-108669
Open Access | Times Cited: 4
Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and Klotho
Ghislaine Gayan‐Ramirez, Wim Janssens
JBMR Plus (2021) Vol. 5, Iss. 12
Open Access | Times Cited: 24
Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure
Joanna Płonka, Agnieszka Olejnik, Anna Klus, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 860-860
Open Access
Genetically Determined α-Klotho Levels and Causal Association with Aging-Related Lung Diseases
Jin Chen, Yuwen Li
Respiratory Medicine (2025), pp. 108081-108081
Closed Access
Pathophysiological changes in patients during hemodialysis and blood reinfusion predict potential development of hemodialysis reactions
Ákos Pethő, Csaba Révész, Tamás Mészáros, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Lower levels of α-Klotho in serum are associated with decreased lung function in individuals with interstitial lung abnormalities
Ivette Buendia‐Roldán, Nancy Machuca, Mayra Mejía, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 28
αKlotho–FGF23 interactions and their role in kidney disease: a molecular insight
Edward R. Smith, S. Holt, Tim D. Hewitson
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 23, pp. 4705-4724
Closed Access | Times Cited: 28
Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK–FGF23 signaling
Wei Lu, Hongqiao Zhu, Jiawen Wu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Phosphate induces inflammation and exacerbates injury from cigarette smoke in the bronchial epithelium
Seth Bollenbecker, Kylie Heitman, Brian Czaya, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Analysis of the correlation between serum Klotho and FeNO: a cross-sectional study from NHANES (2007–2012)
Haiyan Mao, Zhenye Xie, Shanshan Huang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis
Shia Vang, E. Scott Helton, Yiming Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis
Qiqing Huang, Yan Chen, Shaoran Shen, et al.
Aging (2020) Vol. 12, Iss. 7, pp. 5812-5831
Open Access | Times Cited: 23
Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats
Yifeng Luo, Hui Yi, Xinyan Huang, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 321, Iss. 1, pp. L6-L16
Closed Access | Times Cited: 19
FGF19 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice
A. Justet, Mada Ghanem, T. Boghanim, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 67, Iss. 2, pp. 173-187
Closed Access | Times Cited: 14
Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho
Qinglian Wang, Jingshu Sun, Rong Wang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top